PremiumCompany AnnouncementsVimian Group AB Plans EUR 125 Million Bond Issuance Vimian Group AB: Buy Rating Affirmed Amid Nasdaq Uplisting and Market Expansion Vimian Group AB’s Q4 2024 Outperformance: Strong Growth in Specialty Pharma and Diagnostics Drives Positive Outlook